CBD may reduce nicotine withdrawal symptoms, a new study finds

This week, CV Sciences (OTCQB: CVSI) released the results of a preclinical study suggesting that CBD may reduce nicotine withdrawal symptoms in smokeless tobacco users.

The study, carried out in collaboration with researchers from the University of California, San Diego and published on Springer Nature found that CBD prevented nicotine-addicted rats from exhibiting withdrawal symptoms, including increased sensitivity to pain and weight gain during short- and long-term nicotine restriction.

Photo by Mathew MacQuarrie via Unsplash

The company also released its potential plans to develop the world’s first and only FDA-approved treatment for smokeless tobacco addiction.

RELATED: Can CBD Help You Quit Cigarette Smoking?

“We are excited about the results of this study, which was carried out in collaboration with UC San Diego and represents a significant milestone for our drug development department.” Joseph Dowling, CEO of CV Sciences said Benzinga. “Through continuous research and innovation, we strive to develop a CBD-based therapeutic to address the vast unmet medical need and global health problem of nicotine addiction.”

This article originally appeared on Benzinga and was republished with permission.